Phase III study comparing vincristine, doxorubicin (adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma: An Eastern Cooperative Oncology Group study

M. A. Gertz, L. A. Kalish, R. A. Kyle, R. G. Hahn, D. C. Tormey, M. M. Oken

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III study comparing vincristine, doxorubicin (adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma: An Eastern Cooperative Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences